Shenzhen Chipscreen Biosciences Co Ltd
SSE:688321

Watchlist Manager
Shenzhen Chipscreen Biosciences Co Ltd Logo
Shenzhen Chipscreen Biosciences Co Ltd
SSE:688321
Watchlist
Price: 34.2 CNY -1.41% Market Closed
Market Cap: 13.9B CNY

Operating Margin

-2.9%
Current
Improving
by 9.4%
vs 3-y average of -12.3%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-2.9%
=
Operating Income
¥-24.5m
/
Revenue
¥851m

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-2.9%
=
Operating Income
¥-24.5m
/
Revenue
¥851m

Peer Comparison

Country Company Market Cap Operating
Margin
CN
Shenzhen Chipscreen Biosciences Co Ltd
SSE:688321
14.1B CNY
Loading...
US
Eli Lilly and Co
NYSE:LLY
1T USD
Loading...
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP
Loading...
US
Johnson & Johnson
NYSE:JNJ
524.6B USD
Loading...
CH
Roche Holding AG
SIX:ROG
274.9B CHF
Loading...
CH
Novartis AG
SIX:NOVN
219.9B CHF
Loading...
UK
AstraZeneca PLC
LSE:AZN
209.8B GBP
Loading...
US
Merck & Co Inc
NYSE:MRK
276.4B USD
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.7T DKK
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
US
Pfizer Inc
NYSE:PFE
147.2B USD
Loading...
No Stocks Found

Market Distribution

Lower than 72% of companies in China
Percentile
28th
Based on 8 544 companies
28th percentile
-2.9%
Low
-409 046.1% — -1.4%
Typical Range
-1.4% — 10.3%
High
10.3% — 876.4%
Distribution Statistics
China
Min -409 046.1%
30th Percentile -1.4%
Median 4.2%
70th Percentile 10.3%
Max 876.4%

Shenzhen Chipscreen Biosciences Co Ltd
Glance View

Market Cap
13.9B CNY
Industry
Pharmaceuticals

In the bustling city of Shenzhen, often hailed as China's Silicon Valley, Shenzhen Chipscreen Biosciences Co Ltd stands as a testament to innovation in the biopharmaceutical landscape. Founded in 2001, the company embarked on a journey to bridge the gap between cutting-edge bioscience and market needs, focusing on research, development, and commercialization of novel drugs. Chipscreen’s core strength lies in its proprietary chemical genomics-based discovery and development platform, which has carved out a niche in identifying molecular targets and mining drug candidates with high therapeutic potential. The company seamlessly integrates advanced technologies with biotech prowess to design and develop small molecule drugs that address unmet clinical needs, primarily focusing on oncology, autoimmune diseases, and metabolic disorders. The financial engine of Chipscreen Biosciences hums through a well-orchestrated portfolio strategy. By progressing drug candidates through various stages of clinical trials, the company has not only diversified its offerings but also strategically positioned itself in lucrative therapeutic markets. Its revenue model capitalizes on successful product commercialization, primarily through sales of its marketed drugs and royalties from licensing agreements with strategic partners. This collaborative approach enables Chipscreen to maximize its product reach while sharing developmental risks. As the company's innovative therapies gain traction in domestic and global markets, Chipscreen continues its commitment to reinvest in research and development, crafting a sustainable cycle of growth fueled by scientific advancement and strategic acumen.

Intrinsic Value
20.45 CNY
Overvaluation 40%
Intrinsic Value
Price
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
-2.9%
=
Operating Income
¥-24.5m
/
Revenue
¥851m
What is Shenzhen Chipscreen Biosciences Co Ltd's current Operating Margin?

The current Operating Margin for Shenzhen Chipscreen Biosciences Co Ltd is -2.9%, which is above its 3-year median of -12.3%.

How has Operating Margin changed over time?

Over the last 3 years, Shenzhen Chipscreen Biosciences Co Ltd’s Operating Margin has decreased from -1% to -2.9%. During this period, it reached a low of -32.3% on Dec 31, 2023 and a high of 3.1% on Dec 31, 2022.

Back to Top